Global In Vitro Diagnostics Market Report, First Edition: 2025-2030 - Coming Soon!

DeciBio's Global In Vitro Diagnostics Market Report is a comprehensive, data-driven resource available for leaders in the IVD industry. Covering the market from 2025–2030, this comprehensive resource provides a forward-looking view of the global IVD industry, equipping leaders with the insights needed to anticipate shifts, capture opportunities and outpace competitors.

Inside the report, there are detailed forecasts across every major market segment, backed by a deep analysis of growth drivers, challenges, and emerging trends. The report explores each diagnostic modality used for IVD testing, highlighting adoption patterns across technology types and clinical applications. It also provides a therapeutic-area view of the IVD market, with each section analyzing the key drivers and moderators influencing growth, a clear picture of how testing is evolving across the patient journey and analysis of the developments most likely to disrupt and reshape diagnostics in the years ahead.

In addition to these market and clinical insights, the report includes a competitive assessment of the top IVD vendors. This benchmarking enables readers to better understand the strategies shaping today’s leaders and to position themselves to succeed in tomorrow’s market.

The future of IVD is not just about what’s happening today, it’s about what’s coming next. With DeciBio’s independent, data-driven analysis, you will be prepared to anticipate inflection points, identify growth opportunities ahead of competitors, and navigate challenges with confidence.

‍

Key Segmentations Covered:

Diagnostic Modality

• Anatomic Pathology
• Clinical Chemistry
• Coagulation Analysis
• Culture
• Flow Cytometry
• Glucose Strip Monitoring
• Immunoassay
• Mass Spectrometry
• Molecular Diagnostics

Therapeutic Area

• Autoimmune / Inflammatory
• Blood Screening
• Cardiovascular
• Diabetes
• Endocrine
• General Chemistry
• Hematology
• Hemostasis
• Infectious Disease
• Metabolic
• Microbiology
• Oncology
• Reproductive
• Transplant
• Other

Geography

• United States
• Europe
• APAC
• Rest of World

‍

Competitors Profiled:

• Agilent
• Abbott
• BD
• BioMerieux
• Bio-Rad
• Danaher
• Diasorin
• Furjirebio
• Hologic
• QIAGEN
• QuidelOrtho
• Revvity
• Roche
• Siemens Healthineers
• Sysmex
• Thermo Fisher Scientific

‍